Abstract: The new derivative is 6,6-dimethyl-4-oxo-2-formylbicyclo [3.1.1] hept-2-ene. It is obtained by oxidizing verbenone with selenious anhydride. The new compound has interesting therapeutic properties especially at the level of cellular respiration. Medicaments incorporating the new compound may advantageously be used in a basic treatment of cellular respiratory insufficiency, especially respiratory, cardiac and vascular insufficiencies, severe hepatic insufficiency and phenomena of cellular hypoxia due to aging.
August 11, 1975
Date of Patent:
July 19, 1977
So. Ci. Bre.
Raymond Dulou, Pierre Magnin, Pierre Bechtel